Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
64.74 USD | -0.28% | -0.90% | -20.08% |
May. 07 | Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates | MT |
May. 02 | UBS Adjusts Price Target on Gilead Sciences to $70 From $75, Maintains Neutral Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.08% | 80.95B | |
+32.85% | 698B | |
+26.51% | 568B | |
-4.54% | 358B | |
+19.22% | 328B | |
+3.63% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.62% | 165B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Tranche Update on Gilead Sciences, Inc.'s Equity Buyback Plan announced on February 25, 2020.